FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,169 | -55.3% | 33,963 | +0.0% | 0.00% | – |
Q2 2023 | $161,454 | -16.8% | 33,954 | +0.0% | 0.00% | – |
Q1 2023 | $194,115 | +24.8% | 33,938 | +120.1% | 0.00% | – |
Q4 2022 | $155,505 | -99.5% | 15,419 | -99.5% | 0.00% | -100.0% |
Q3 2022 | $31,960,929 | -10.2% | 2,849,452 | +98.5% | 0.02% | -4.0% |
Q2 2022 | $35,572,000 | -37.6% | 1,435,513 | -2.3% | 0.02% | -10.7% |
Q1 2022 | $56,970,000 | -36.9% | 1,469,400 | -4.7% | 0.03% | -26.3% |
Q4 2021 | $90,259,000 | -11.6% | 1,542,604 | -10.4% | 0.04% | -15.6% |
Q3 2021 | $102,052,000 | -35.6% | 1,721,811 | -5.7% | 0.04% | -33.8% |
Q2 2021 | $158,477,000 | +1.1% | 1,825,984 | -3.9% | 0.07% | -5.6% |
Q1 2021 | $156,707,000 | -32.3% | 1,900,632 | -25.3% | 0.07% | -33.3% |
Q4 2020 | $231,467,000 | +82.9% | 2,545,568 | -19.6% | 0.11% | +63.6% |
Q3 2020 | $126,574,000 | +0.8% | 3,166,709 | -13.5% | 0.07% | -5.7% |
Q2 2020 | $125,556,000 | +71.5% | 3,659,394 | +11.0% | 0.07% | +40.0% |
Q1 2020 | $73,196,000 | +37055.3% | 3,295,619 | +32685.7% | 0.05% | – |
Q4 2019 | $197,000 | – | 10,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |